{"title":"Anticonvulsant drugs, behavior, and cognitive abilities.","authors":"M Trimble","doi":"10.1007/978-94-011-8123-5_3","DOIUrl":"https://doi.org/10.1007/978-94-011-8123-5_3","url":null,"abstract":"<p><p>The literature concerning the relationship of anticonvulsant drugs to disturbances of behavior and cognitive abilities has been reviewed. It is indicated that although completed studies are sparse and although many of the techniques currently used for evaluating the effects os such drugs on patients are inadequate, certain conclusions may be drawn. With regard to the effects on cognitive abilities, the drugs not only impair performance on psychological tests, but some drugs--particularly phenytoin--are associated with a progressive decline of intellectual abilities, which is often insidious and unrecognized. There is little systematic evidence to indicate which anticonvulsant drugs have adverse effects on behavior, but several studies have indicated improvements in behavior associated with carbamazepine and sulthiame. The possible reasons why anticonvulsant drugs should have those effects are discussed, and particularly the relationship of the drugs to abnormal folic acid and monoamine and metabolism are highlighted.</p>","PeriodicalId":75756,"journal":{"name":"Current developments in psychopharmacology","volume":"6 ","pages":"65-91"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18061809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Behavioral effects of opiates: a pharmacogenetic analysis.","authors":"A Oliverio, C Castellano","doi":"10.1007/978-94-011-8123-5_2","DOIUrl":"https://doi.org/10.1007/978-94-011-8123-5_2","url":null,"abstract":"<p><p>A number of studies are reviewed in relation to a pharmacogenetic approach to the effect of opiates. The behavioral effects of morphine and heroin in different species or strains of animals are considered. In particular, a number of behavioral, neurophysiological, and biochemical correlates of the opiates in different inbred strains of mice are cited. Recent studies concerning the effects of opiates on behavior have utilized the C57BL/6J and the DBA/2J strains, which are characterized by different brain levels and turnover of cholinergic and adrenergic mediators. It has been shown that the effects of opiates on running activity and on analgesia are strain-dependent, and a negative correlation is evident between the two measures in the strains considered. Experiments carried out on mice with septal lesions and on normal mice have confirmed that the motor and analgesic effects of morphine in the mouse are two distinct phenomena, which may be explained through different neurophysiological and biochemical models. Differences between the strains considered have also been observed when the ECoG response to morphine administration has been investigated. The results of these experiments have suggested: 1. The existence of a correlation between behavioral activation and sleep-like ECoG patterns. 2. The existence of a similarity between the effects of the anticholinergic drugs and those of morphine, since a dissociation between ECoG and behavior became evident following morphine administration. Some studies have also suggested that the environmental factors play an important role in determining the stimulating effects of morphine. This effect was absent in \"experience\" mice (i.e., in subjects already tested in the apparatus), as compared with naive \"inexperienced\" animals.</p>","PeriodicalId":75756,"journal":{"name":"Current developments in psychopharmacology","volume":"6 ","pages":"45-64"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18061808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparative psychopharmacology.","authors":"K Y Lagerspetz","doi":"10.1007/978-94-011-8123-5_1","DOIUrl":"https://doi.org/10.1007/978-94-011-8123-5_1","url":null,"abstract":"<p><p>Studies of the effects of psychoactive drugs and neurotransmitters on the behavior of invertebrates and poikilothermic vertebrates are reviewed. Dangers of reductive explanations are pointed out. Results and suggestions are given concerning the use of poikilothermic animals (1) in the development of screening tests, (2) in experiments on the action mechanisms of psychopharmaca, and (3) in the use of psychoactive drugs in the study of the mechanisms of animal behavior.</p>","PeriodicalId":75756,"journal":{"name":"Current developments in psychopharmacology","volume":"6 ","pages":"1-43"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18062901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nicotine and smoking.","authors":"R Kumar, M Lader","doi":"10.1007/978-94-011-8123-5_5","DOIUrl":"https://doi.org/10.1007/978-94-011-8123-5_5","url":null,"abstract":"","PeriodicalId":75756,"journal":{"name":"Current developments in psychopharmacology","volume":"6 ","pages":"127-64"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/978-94-011-8123-5_5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18062902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Chronopharmacological studies of neuroleptics.","authors":"H Nagayama, A Takagi, R Takahashi","doi":"10.1007/978-94-011-8123-5_7","DOIUrl":"https://doi.org/10.1007/978-94-011-8123-5_7","url":null,"abstract":"<p><p>Studies were carried out to clarify the mechanism of appearance and the laws controlling the appearance of such phenomena as circadian fluctuation in the effects of neuroleptics. A detailed review was initially made of previous studies on drugs closely related to neuroleptics; then data obtained by the authors was analyzed. Significant circadian fluctuation was found in the effect of chlorpromazine, haloperidol, and tetrabenazine, varying with the time of administration, with the kind of drug, and even with the dose of the same drug. There was also circadian fluctuation in lethality rate, which was seen to be a phenomenon controlled by a law different from that controlling circadian fluctuation in the effect of a drug. Circadian fluctuation in the effect of a drug was regulated externally by clock time, setting the light-dark rhythm of the raising environment. Different times of administration of a drug did not affect chronological changes in the blood level or intracerebral concentration of a drug after administration. From these results, it was assumed that this phenomenon might be induced by the circadian rhythm of drug sensitivity of a brain where the drug acts.</p>","PeriodicalId":75756,"journal":{"name":"Current developments in psychopharmacology","volume":"6 ","pages":"191-214"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17178644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Drug-induced tardive dyskinesia.","authors":"H Itoh","doi":"10.1007/978-94-011-8123-5_4","DOIUrl":"https://doi.org/10.1007/978-94-011-8123-5_4","url":null,"abstract":"<p><p>Drug-induced tardive dyskinesia, which occurs in the course of long-term administration of psychotropic drugs, especially neuroleptics, and persists for years even after drug removal, began to be reported in the late 1950s. Since then, more than 100 investigations on this subjects have been described. And it is estimated that 10 to 30 percent of long-term hospitalized psychiatric patients in Europe and North America exhibit tardive dyskinesia, whereas 5 to 20 percent of patients exhibit this syndrome in Japan. These findings suggest that the manifestation of tardive dyskinesia will become a serious problem in the investigation of psychotropic drug treatment. The author presents a review of the symptomatology, etiological factors, differential diagnosis, prognosis, and management of this syndrome. Results of the author's studies in the cross-national survey and on the reversibility of tardive dyskinesia are also described. In connection with biochemical theory of the etiology of tardive dyskinesia, a variety of therapeutic investigations have been carried out, but no successful therapy could be found among them. Therefore, the author stresses that the early diagnosis of dyskinetic symptoms, possible removal of responsible drugs, and preventive care in daily psychotropic drug treatment are regarded as extremely important in the management of this syndrome.</p>","PeriodicalId":75756,"journal":{"name":"Current developments in psychopharmacology","volume":"6 ","pages":"93-126"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17178645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The effects of D-amphetamine on dopaminergic regulated mechanisms of physiological and behavioral thermoregulation.","authors":"S Yehuda","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":75756,"journal":{"name":"Current developments in psychopharmacology","volume":"5 ","pages":"125-71"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11582903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J C Schwartz, G Barbin, M Baudry, M Garbarg, M P Martres, H Pollard, M Verdiere
{"title":"Metabolism and functions of histamine in the brain.","authors":"J C Schwartz, G Barbin, M Baudry, M Garbarg, M P Martres, H Pollard, M Verdiere","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":75756,"journal":{"name":"Current developments in psychopharmacology","volume":"5 ","pages":"173-261"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11306895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Psychobiological interactions and schizophrenia.","authors":"D Shore","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":75756,"journal":{"name":"Current developments in psychopharmacology","volume":"5 ","pages":"263-91"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11258521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}